Aimmune Therapeutics Stock News

Stocks Analysis by Zacks Investment Research covering: Dow Jones Industrial Average, Caterpillar Inc, UnitedHealth Group Incorporated. Read Zacks Investment Research's latest article on Investing.com

Diversified Trust Co bought a new stake in Aimmune Therapeutics Inc (NASDAQ:AIMT) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bo

Aimmune Therapeutics (NASDAQ:AIMT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “

Zacks Investment Research upgraded shares of Aimmune Therapeutics (NASDAQ:AIMT) from a hold rating to a buy rating in a research note published on Thursday morning, Zacks.com reports. The firm current

Shares of Aimmune Therapeutics Inc (NASDAQ:AIMT) have been assigned an average rating of “Buy” from the fourteen brokerages that are covering the company, Marketbeat Ratings reports. One research

Aimmune Therapeutics Inc (NASDAQ:AIMT) – Investment analysts at Piper Sandler dropped their Q2 2020 earnings per share (EPS) estimates for Aimmune Therapeutics in a research note issued to investors

Aimmune Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

InvestorPlace.com's Best Stocks for 2020 contest looks dismal after Q1. What will happen with the pandemic, and which stock will win?

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gilead Sciences (GILD

Stocks Move Lower but Stay Calm After Dreary Jobs Report